Health Wire Taiwan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Taiwan.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 30, 2026

11 hours ago

賦能藥研創新：華生株式会社聚焦細胞研究資料支持，協助早期藥物發現

EIN Presswire

an hour ago

NEOMED earns accreditation for new Certified Mental Health Assistant program and becomes first in the nation to offer the innovative degree

GlobeNewswire

an hour ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

GlobeNewswire

an hour ago

Crescent Biopharma Announces Grants of Inducement Awards

GlobeNewswire

an hour ago

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

GlobeNewswire

an hour ago

NurExone Appoints Eyal Gabbai to Board, Adding Large-Scale Healthcare System and Capital Markets Expertise

GlobeNewswire

an hour ago

Olema Oncology Announces Departure of Chief Operating and Financial Officer

GlobeNewswire

2 hours ago

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders

GlobeNewswire

5 hours ago

Dr. Christina Rahm and Clayton Thomas of The ROOT Brands Attend World Economic Forum Annual Meeting 2026 in Davos

GlobeNewswire

5 hours ago

Dr. Linette Williamson Expands Integrative Medicine Services in Encinitas With Physician-Supervised Ozone Sauna Therapy

GlobeNewswire

5 hours ago

CrazyBulk: SARM Alternatives for Bulking, Strength and Performance or Just Hype?

GlobeNewswire

6 hours ago

OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting

GlobeNewswire

6 hours ago

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma

GlobeNewswire

7 hours ago

Global Virus Network Statement on Nipah Virus Outbreak

GlobeNewswire

8 hours ago

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

GlobeNewswire

8 hours ago

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

GlobeNewswire

8 hours ago

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

GlobeNewswire

8 hours ago

Global Drug Device Combination Products Market to Reach USD 379.17 Billion by 2030 | MarketsandMarkets™

GlobeNewswire

8 hours ago

Standard BioTools Completes Sale of SomaLogic to Illumina

GlobeNewswire

8 hours ago

Scilex Holding Company Announces $20 Million Strategic Investment in Quantum Scan Holdings, Inc., Targeting Trillion-Dollar Preventive Diagnosis and Prognosis Markets

GlobeNewswire